Rocketvax AG, a subsidiary of Swiss Rockets AG, is recognized as an emerging player in the biotechnology sector. Being chosen to partake in the Sparks IPO Academy reflects the company’s commitment to enhancing its corporate structure and project development strategies.
The Sparks IPO Academy provides a customized preparation environment for Rocketvax AG, offering access to Switzerland's leading capital markets specialists, networking with CFOs of listed companies, engaging with potential investors, and connecting with peers on the IPO journey, all aimed at achieving IPO readiness. The SIX Swiss Exchange's initiative, in particular through the Sparks listing segment, aims to provide SMEs with the necessary resources for a successful transition to the public markets in line with their sustainable business growth.
Albert Muntané, CFO of Rocketvax AG, comments: “Our acceptance into the SIX Swiss Exchange Sparks IPO Academy is a testament to the hard work of our team and the innovative potential of our projects. We see going public as a strategic avenue to not only secure necessary funding for our future endeavors, but also to demonstrate our dedication to driving shareholder value. This academy will serve as a critical resource in realizing our vision.”
The six-month program is a hybrid structure that allows participants like Rocketvax AG to fully maintain their operational commitments while gaining valuable insight into the IPO process.